Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.37 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.37 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.37 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.37 |
| ▸ | GALR3 | O60755 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | BLM | P54132 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | PDE4A | P27815 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.34 |
| ▸ | PRKCA | P17252 | 2/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28404010 | 0.86 | LMNA (0.43) | TSHRCHRM2CHRM4CHRM1TBXA2R | |
| SCHEMBL347296 | 0.82 | TDP1 (0.50) | TSHRCHRM2CHRM4CHRM1TBXA2R | |
| SCHEMBL349281 | 0.82 | TDP1 (0.50) | TSHRCHRM2CHRM4CHRM1TBXA2R | |
| SCHEMBL28363638 | 0.81 | PDE4A (0.32) | LMNAL3MBTL1PDE4ATDP1USP2 | |
| SCHEMBL7776197 | 0.80 | TSHR (0.42) | TSHRCHRM2CHRM4CHRM1TBXA2R | |
| SCHEMBL18880921 | 0.80 | TDP1 (0.43) | TSHRCHRM2CHRM4CHRM1TBXA2R | |
| SCHEMBL11472471 | 0.78 | TDP1 (0.42) | TSHRCHRM2CHRM4CHRM1TBXA2R | |
| SCHEMBL13687836 | 0.78 | TDP1 (0.42) | TSHRCHRM2CHRM4CHRM1TBXA2R | |
| SCHEMBL11710808 | 0.78 | TSHR (0.41) | TSHRPDE4A | |
| SCHEMBL396999 | 0.76 | TSHR (0.39) | TSHRCHRM2CHRM4CHRM1TBXA2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3417724-B1 | METHOD FOR PROCESSING HEAT-NOT-BURN CIGARETTES | GUANGDONG GOLDEN LEAF TECH DEVELOPMENT CO LTD (CN) | 2024-12-04 | — | — | EP | claimed |
| EP-2627708-B1 | DISPERSANT CONTAINING GYPSUM SLURRY | BASF CONSTRUCTION POLYMERS GMBH (DE) | 2020-05-13 | — | — | EP | claimed |
| EP-2473457-B1 | FORMULATION AND ITS USE | BASF CONSTR POLYMERS GMBH (DE) | 2014-10-08 | — | — | EP | claimed |
| US-20130330532-A1 | DISPERSANT CONTAINING GYPSUM SLURRY | BASF CONSTRUCTION POLYMERS GMBH (DE) | 2013-12-12 | — | — | US | claimed |
| EP-2627708-A2 | DISPERSANT CONTAINING GYPSUM SLURRY | BASF Construction Polymers GmbH (DE) | 2013-08-21 | — | — | EP | claimed |
| US-20130005861-A1 | FORMULATION AND ITS USE | DIERSCHKE FRANK (DE) | 2013-01-03 | — | — | US | claimed |
| US-20120308840-A1 | FORMULATION AND USE THEREOF | BASF SE (DE) | 2012-12-06 | — | — | US | claimed |
| EP-2473457-A1 | FORMULATION AND ITS USE | BASF Construction Polymers GmbH (DE) | 2012-07-11 | — | — | EP | claimed |
| WO-2012049077-A2 | DISPERSANT CONTAINING GYPSUM SLURRY | BASF CONSTRUCTION POLYMERS GMBH (DE) | 2012-04-19 | — | — | WO | claimed |
| WO-2011029711-A1 | FORMULATION AND ITS USE | BASF CONSTRUCTION POLYMERS GMBH (DE) | 2011-03-17 | — | — | WO | claimed |
| US-20110054081-A1 | FORMULATION AND ITS USE | BASF CONSTRUCTION POLYMERS GMBH (DE) | 2011-03-03 | — | — | US | claimed |
| WO-2026099480-A1 | NONWOVEN FABRIC AND ITS USE FOR ORAL DOSAGE FORMS | CARL FREUDENBERG KG (DE) | 2026-05-15 | — | — | WO | disclosed |
| EP-4740754-A1 | NONWOVEN FABRIC AND ITS USE FOR ORAL DOSAGE FORMS | Carl Freudenberg KG (DE) | 2026-05-13 | — | — | EP | disclosed |
| EP-4335466-A1 | COMPOSITION FOR THE PREPARATION OF A BONE SUBSTITUTE MATERIAL, METHOD FOR THE PREPARATION OF A PHARMACEUTICAL ACTIVE SUBSTANCE CARRIER, PHARMACEUTICAL ACTIVE SUBSTANCE CARRIER AND ITS USE | Heraeus Medical GmbH (DE) | 2024-03-13 | — | — | EP | disclosed |
| EP-3798276-B1 | AQUEOUS PAINT COMPOSITION | ARCOLOR AG (CH) | 2023-06-07 | — | — | EP | disclosed |
| WO-2012049077-A2 | DISPERSANT CONTAINING GYPSUM SLURRY | BASF CONSTRUCTION POLYMERS GMBH (DE) | 2012-04-19 | — | — | WO | disclosed |
| WO-2011029711-A1 | FORMULATION AND ITS USE | BASF CONSTRUCTION POLYMERS GMBH (DE) | 2011-03-17 | — | — | WO | disclosed |
| WO-2011028817-A1 | ADDITIVES IN GYPSUM PANELS AND ADJUSTING THEIR PROPORTIONS | UNITED STATES GYPSUM COMPANY (US) | 2011-03-10 | — | — | WO | disclosed |
| US-20110054081-A1 | FORMULATION AND ITS USE | BASF CONSTRUCTION POLYMERS GMBH (DE) | 2011-03-03 | — | — | US | disclosed |
| US-20110054053-A1 | ADDITIVES IN GYPSUM PANELS AND ADJUSTING THEIR PROPORTIONS | UNITED STATES GYPSUM COMPANY | 2011-03-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120308840-A1 | FORMULATION AND USE THEREOF | SMCHD1, SMS, PEF1 | TSHR 4692/4885CHRM2 1389/4885CHRM4 2194/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.